Fall 2018 - Integrated Care

Flu Vaccine Recommendations Updated by CDC and AAP

The Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices has updated its 2017-18 recommendations regarding the use of seasonal influenza (flu) vaccines and guidance for vaccine providers about the use of flu vaccines for the 2018-19 season. These include:

1) The vaccine virus composition for 2018-19 U.S. seasonal influenza vaccines;

2) A recommendation for the 2018-19 season that the live-attenuated influenza vaccine is an option for flu vaccination of persons for whom it is appropriate;

3) A recommendation that persons with a history of egg allergy may receive any licensed, recommended and age-appropriate influenza vaccine; and

4) Recent regulatory actions, including new vaccine licensures and labeling changes for previously licensed vaccines.

The complete set of recommendations can be viewed at www.cdc.gov/mmwr/ volumes/67/rr/rr6703a1.htm?s_cid=rr 6703a1_e.

References

  1. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2018–19 Influenza Season. Centers for Disease Control and Prevention, Aug. 24, 2018 Accessed at www.cdc.gov/mmwr/volumes/67/rr/rr6703a1.htm?s_cid=rr6703 a1_e.
  2. AAP Issues Flu Vaccine Recommendations for 2018-2019. American Academy of Pediatrics press release, Sept. 3, 2018. Accessed at www.aap.org/en-us/about-the-aap/aap-press-room/Pages/AAPIssues-Flu-Vaccine-Recommendations-for-2018-2019.aspx.
BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.